A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of MK-0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of MK-0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Nov 2013

At a glance

  • Drugs Anacetrapib (Primary) ; Atorvastatin
  • Indications Hypercholesterolaemia; Lipid metabolism disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Nov 2009 Results were reported at the 82nd Annual Scientific Sessions of the American Heart Association.
    • 18 Nov 2009 Updated results reported at the 82nd Annual Scientific Sessions of the American Heart Association.
    • 08 Oct 2007 Drug name changed from MK 0859 to anacetrapib.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top